Literature DB >> 21199736

Methionine sulfoximine may improve inflammation in autism, a novel hypothesized treatment for autism.

Ahmad Ghanizadeh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21199736     DOI： 10.1016/j.arcmed.2010.10.012

Source DB:  PubMed          Journal:  Arch Med Res        ISSN： 0188-4409            Impact factor:   2.235


× No keyword cloud information.
  7 in total

1.  Targeting Mitochondria by Olesoxime or Complement 1q Binding Protein as a Novel Management for Autism: A Hypothesis.

Authors:  A Ghanizadeh
Journal:  Mol Syndromol       Date:  2011-10-12

2.  N-acetylcysteine for treatment of autism, a case report.

Authors:  Ahmad Ghanizadeh; Nima Derakhshan
Journal:  J Res Med Sci       Date:  2012-10       Impact factor: 1.852

3.  A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.

Authors:  Ahmad Ghanizadeh; Ebrahim Moghimi-Sarani
Journal:  BMC Psychiatry       Date:  2013-07-25       Impact factor: 3.630

4.  Physical exercise and intermittent administration of lactulose may improve autism symptoms through hydrogen production.

Authors:  Ahmad Ghanizadeh
Journal:  Med Gas Res       Date:  2012-07-30

5.  Hyperbaric oxygen therapy for treatment of children with autism: a systematic review of randomized trials.

Authors:  Ahmad Ghanizadeh
Journal:  Med Gas Res       Date:  2012-05-11

Review 6.  Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism.

Authors:  Ahmad Ghanizadeh
Journal:  Dis Markers       Date:  2013-09-12       Impact factor: 3.434

Review 7.  Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature.

Authors:  Hui-Fei Zheng; Wen-Qiang Wang; Xin-Min Li; Gail Rauw; Glen B Baker
Journal:  Amino Acids       Date:  2016-09-29       Impact factor: 3.520
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.